share_log

Biotechnology Market: Surging Investments and Infrastructure Development Propel 13.9% CAGR by 2031| SkyQuest Technology

Biotechnology Market: Surging Investments and Infrastructure Development Propel 13.9% CAGR by 2031| SkyQuest Technology

生物技術市場:投資激增和基礎設施發展促使在2031年實現13.9%的複合年增長率 | SkyQuest Technology
PR Newswire ·  07/18 10:30

WESTFORD, Mass., July 18, 2024 /PRNewswire/ -- According to SkyQuest, the global Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

根據SkyQuest的數據顯示,全球生物技術市場規模在2022年達到USD 1.21萬億,2023年將從USD 1.38萬億增長到2031年的USD 3.9萬億,預計在2024-2031年間的預測期內以13.9%的複合年增率增長。

Biotechnology is a diversified, innovative industry that uses organisms, biological systems, or their products to modify or develop processes and by-products to produce health-related products and treatments.

生物技術是一個多樣化、創新的行業,利用生物體、生物系統或其產品來修改或開發進程和副產品以生產與健康相關的產品和治療方案。

Biotechnology and related products are required to meet established regulatory guidelines and standards. The major federal agencies in the US responsible for administering the required standards are the Animal and Plant Health Inspection Service (APHIS), US. The Coordinated Framework for the Regulation of Biotechnology outlines a government framework for evaluating products developed using modern biotechnology. This provision is based on existing laws developed to protect public health and the environment.

生物技術及其相關產品需要符合既定的規定和標準。美國主要聯邦機構主管所需的標準是動植物衛生檢驗局(APHIS),協調生物技術監管框架概述了一種用於評估使用現代生物技術開發的產品的政府框架。此規定是基於已制定的旨在保護公共衛生和環境的現有法律。

Download a detailed overview:

下載詳細概述:

Biotechnology Market Overview:

生物技術市場概況:

Report Coverage

Details

Market Revenue in 2023

USD 1.38 Trillion

Estimated Value by 2031

USD 3.90 Trillion

Growth Rate

Poised to grow at a CAGR of 13.9%

Forecast Period

2024–2031

Forecast Units

Value (USD Trillion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Type, Product, Technology, Application and Region

Geographies Covered

North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Growth in Nanobiotechnology

Key Market Drivers

Growing Research and Development of Tissue Culture and Cell Engineering

報告涵蓋內容

詳情

2023年市場收入:

USD 1.38萬億

2031 年預計價值

USD 3.9萬億

增長率

預計在未來的13.9%的複合年增率增長。

預測期間

2024 年至 2031 年

預測單位

價值(萬億美元)

報告涵蓋內容

營收預測,競爭情況,增長因素和趨勢

覆蓋的板塊

類型、產品、技術、應用和地域版塊

涵蓋的地域

北美洲、歐洲、亞太地區、中東和非洲、拉丁美洲

報告亮點

玩家的最新財務信息/產品組合

關鍵市場機遇

生物納米技術中的增長

關鍵市場驅動因素

組織培養和細胞工程的不斷髮展

Segments covered in Biotechnology Market are as follows:

生物技術市場涵蓋以下幾個方面:

  • Type
    • Blue Biotechnology, Green Biotechnology, Red Biotechnology, White Biotechnology, Others
  • Product
    • Instrument & Reagent (Clinical Diagnostics, Proteomics and genomics, Drug Discovery & Development, Cell Analysis, Others), Software & Service
  • Technology
    • Nanobiotechnology, PCR Technology, Bioinformatics, Tissue Engineering, DNA sequencing, Fermentation Technology, Others
  • Application
    • Health, Agriculture, Food and Beverages, Industrial Processing, Others
  • 類型
    • 藍色生物科技、綠色生物技術、紅色生物技術、白色生物技術、其他
  • 產品
    • 儀器與試劑(臨床診斷、蛋白質組學和基因組學、藥物開發與研究、細胞分析、其他)、軟件和服務
  • 科技
    • 生物納米技術、PCR技術、生物信息學、組織工程、DNA測序、發酵技術、其他
  • 應用
    • 醫療保健、農業、食品和飲料、工業加工、其他

Request Free Customization of this report:

免費定製本報告:

DNA Sequencing Holds a Dominant Position in the Biotechnology Market Owing to the Rising Adoption of Advanced Techniques

DNA測序由於採用高級技術的普及而在生物技術市場佔據主導地位

DNA sequencing occupies a dominant position in the biotechnology market, accounting for about 17.43% by 2023. This growth is due to two main factors: cheaper sequencing costs and the adoption of advanced techniques and government funding also plays an important role. A grant like the one awarded by the NIH (National Institutes of Health) that may be $10.7 million by May 2021, directed toward understanding the genetics of Alzheimer's disease, is an example of this kind of funding. Such funding fuels research and it opens new applications for DNA sequencing, ideal for various diseases.

DNA測序佔據着生物技術市場的主導地位,到2023年佔比約爲17.43%。這種增長由兩個主要因素推動:測序成本更低以及採用高級技術和政府資金的使用。NIH(國立衛生研究院)授予的1070萬美元的撥款是資金的一個例子,該撥款是在2021年5月之前針對了解阿茲海默病基因的方向。這種資金推動研究,爲DNA測序開拓了新的應用,對各種疾病非常理想。

The nanobiotechnology segment is poised to surge from 2024 to 2031. Two main factors fuel this growth: more nanomedicine approvals and remarkable growth in the sector. In addition, nanoparticles for diagnosis are revolutionizing disease diagnosis, allowing for comparative diagnosis and personalized medicine simultaneously. Tissue technology and regenerative medicine is growing due to government and private investments, high healthcare spending, and the rise of established and new players.

隨着納米醫學審批的增加以及該領域的顯著增長,生物納米技術領域將在2024年至2031年間迎來飛速增長。此外,用於診斷的納米顆粒正在改變疾病診斷,使比較診斷和個體化治療同時實現。由於政府和私人投資、高額醫療保健支出以及已經成立的和新興的參與者的增長,組織工程和再生醫學正在快速增長。

View report summary and Table of Contents (TOC):

查看報告摘要和目錄(TOC):

Healthcare Industry Led the Market Owing to the Enhance Revenue Generation

醫療保健行業引領市場,增強了營業收入的產生。

The healthcare industry led the market and is expected to register a compound annual growth rate (CAGR) of 13.9% throughout the forecast period. Healthcare biotechnology has proven its importance, emerging as the biggest revenue generator by 2020. Biotechnology innovation has given birth to new sectors of the economy, driven largely by small start-ups and interagency collaboration as they are also being used for further treatments to improve the sector. For example, in April 2020, Amgen and Adaptive Biotechnologies collaborated to identify and develop anti-SARS-CoV-2 vaccines using Adaptive's proprietary immunotherapy platform to find antibodies that neutralize viruses This agreement is expected this will significantly increase revenue in this sector.

醫療保健行業引領市場,並有望在預測期內註冊複合年增長率(CAGR)爲13.9%。到2020年,醫療生物技術已經證明了它的重要性,成爲最大的營業收入生成器。生物技術創新誕生了經濟的新部門,這些部門主要由小型創業公司和機構之間的合作推動,因爲它們還被用於進一步的治療以改善該行業。例如,2020年4月,安進和適應性生物技術合作利用適應性的專有免疫療法平台尋找中和病毒的抗體來鑑定並開發抗SARS-CoV-2疫苗。預計該協議將顯着增加該領域的收入。

The food and agriculture sector ranks second in the market. The tools used in agriculture have evolved rapidly, including micropropagation, tissue culture, molecular breeding, marker-assisted selection, genetic engineering, genetically modified (GM) crops, molecular diagnostic technologies, and new genetics providing a comprehensive understanding of plant biology. Moreover, the global adoption of GM crops is expected to boost the segments. GM crops, especially herbicide-resistant and pest-resistant seeds, have become increasingly popular, boosting the agricultural industry.

食品和農業部門在市場上排名第二。農業中使用的工具已經快速發展,包括微型繁殖、組織培養、分子育種、標記輔助選擇、遺傳工程、轉基因(GM)作物、分子診斷技術和新基因組學等提供了對植物生物學的全面理解。此外,全球採用Gm作物的預計將推動該領域。Gm作物,特別是抗除草劑和抗蟲害種子,越來越受歡迎,推動了農業行業的發展。

Biotechnology Market: Shaping the Future of Innovation

生物技術市場:塑造創新未來

The market is at the forefront of scientific and technological innovation, poised to deliver transformative solutions to some of the world's most pressing challenges. Focusing on areas such as healthcare, agriculture and environmental sustainability, biotechnology is driving progress through cutting-edge research and development.

市場處於科技創新的前沿,準備通過前沿研究和開發提供變革性的解決方案,解決一些全球最緊迫的挑戰。生物技術專注於醫療保健、農業和環境可持續性等領域,通過前沿研究和開發推動進步。

Advances in genetic engineering, bioinformatics and bioprocessing technologies are fueling the growth of this market. Specialty areas such as personalized medicine, gene therapy and sustainable agricultural practices can benefit from these innovations, delivering results and efficiency.

遺傳工程、生物信息學和生物處理技術的進步正在推動該市場的增長。個性化醫學、基因療法和可持續農業等專業領域可以從這些創新中受益,實現結果和效率。

Strategic dialogue, investment in R&D and a favorable regulatory environment are going to drive the biotechnology market. Companies are constantly exploring new frontiers, from CRISPR-based gene editing to biotechnology, to unlock and address new possibilities.

戰略對話、研發投資和有利的法規環境將推動生物技術市場的發展。公司不斷探索新的領域,從CRISPR基因編輯到生物技術,以開啓和解決新的可能性。

Related Reports:

相關報告:

Biotechnology & Pharmaceutical Services Outsourcing Market

生物技術和製藥服務外包市場

Plant Biotechnology Services Market

植物生物技術服務市場

Marine Biotechnology Market

海洋生物技術市場

Genomics Market

基因組市場

Digital Health Market

互聯網醫療市場

About Us:

關於我們:InsightAce Analytic是一家市場研究和諮詢公司,可以幫助客戶做出戰略決策。我們提供定性和定量的市場情報解決方案,以滿足市場和競爭情報的需求,以擴大業務。我們通過識別未開發的市場、探索新的和競爭的技術、分割潛在的市場和重新定位產品來幫助客戶獲得競爭優勢。我們的專業知識在於提供深入分析、帶有關鍵市場見解的綜合和定製的市場情報報告,並以及及時和經濟高效的方式。

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

SkyQuest是一家IP專注的研究、投資銀行和技術、資產加速器。我們提供跨行業的技術、市場和金融方面的機會,涵蓋生命科學、清潔科技、農業科技、納米科技和信息與通信技術等領域。

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.

我們與創新者、發明家、創新尋求者、企業家、公司和投資者緊密合作,利用外部研發資源。此外,我們幫助他們優化其知識產權的經濟潛力。我們在創新管理和商業化方面的經驗已經擴展到北美、歐洲、東盟和亞太地區。

Contact:
Mr. Jagraj Singh
SkyQuest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: [email protected]
Visit Our Website:

聯繫方式:
Mr. Jagraj Singh
SkyQuest Technology
1 Apache Way,
Westford,
Massachusetts 01886
美國 (+1) 351-333-4748
電子郵件:[email protected]
訪問我們的網站:

Logo:

徽標:

SOURCE SkyQuest Technology

消息來源SkyQuest Technology

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論